Filter
71
Text search:
sinopharm
Featured
Recommendations
8
New Publications
1
Language
Document type
Guidelines
25
Studies & Reports
18
Manuals
9
Fact sheets
8
Situation Updates
5
Strategic & Response Plan
3
Resource Platforms
2
No document type
1
Countries / Regions
Argentina
10
Brazil
6
Paraguay
4
Mozambique
3
Ukraine
3
Nigeria
2
Germany
2
Syria
2
Colombia
2
Chile
2
East and Southern Africa
2
West and Central Africa
2
Latin America and the Carribbean
2
Senegal
1
Guinea-Bissau
1
Ethiopia
1
Zimbabwe
1
Kenya
1
Rwanda
1
Namibia
1
Ecuador
1
El Salvador
1
Angola
1
Middle East and North Africa
1
South–East Asia Region
1
Africa
1
Congo-Brazzaville
1
Authors & Publishers
Publication Years
Category
Countries
45
Clinical Guidelines
2
Pharmacy & Technologies
1
Toolboxes
COVID-19
61
Conflict
3
Refugee
2
AMR
1
Pharmacy
1
Wenn geflüchtete Menschen aus Kriegs- oder Krisengebieten, wie der Ukraine, nach Deutschland kommen, sollten ihnen frühzeitig alle Impfungen angeboten werden, die die Ständige Impfkommission (STIKO) für die in Deutschland lebende Bevölkerung empfiehlt. Ein aktueller Impfschutz ist entscheidend,
...
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp
...
Available in different languages
This report describes findings from a telephone survey with 1,333 people conducted in February 2021. The survey examined how people respond to public health and social measures (PHSMs) to prevent COVID-19. The sample is representative of households with access to a landline or cell phone, but does n
...
Introduction: Considering the global prevalence of coronavirus disease 2019 (COVID-19), a vaccine is being developed to control the disease as a complementary solution to hygiene measures—and better, in social terms, than social distancing. Given that a vaccine will eventually be produced, informa
...
Child and adolescent vaccine safety report
This report on the safety of COVID-19 vaccination in children and adolescents in Argentina includes data from the start of the adolescent campaign
in Argentina, includes data reported since the start of the campaign in adolescents (28 July 2021) and in ch
...
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
La prévalence de la covid -19 chez la femme enceinte et les accouchées semble être faible. Elles étaient asymptomatiques et le pronostic maternel était satisfaisant. Néanmoins, le risque de for.pdf
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage existing surveillance systems for Severe Acute Respirato
...
Europe and Central Asia Economic Update.
The Russian Federation’s war with Ukraine has triggered a catastrophic humanitarian crisis and threatened the stability of geopolitical relations. Economic output in the Europe and Central Asia region is forecast to contract by more than 4.1% in 2022—the
...
January 2020 to December 2021
Considerations for implementing and adjusting public health and social measures in the context of COVID-19
recommended
interim guidance, 14 June 2021
This document is intended for national authorities and decision makers in countries that have introduced large scale public health and social measures. It offers guidance for adjusting public health and social measures, while managing the risk of a resurgence of cases
...
Vaccinator's Manual. Pfizer-BioNTech Comirnaty Vaccine
module de la série d’évaluation des capacités des services de santé dans le contexte de la pandémie de COVID-19, 7 juillet 2021
The number of COVID-19 cases is on the rise again, with South Africa nearing half of all confirmed cases in the WHO African Region. Threats of new variants loom and low vaccination coverage raises questions on the future of the response to COVID-19. Prevention remains the key strategy in most sub-Sa
...
